Hygroton (chlortalidone)
/ Alliance
- LARVOL DELTA
Home
Next
Prev
1 to 10
Of
10
Go to page
1
September 23, 2025
Aldosterone, the Mineralocorticoid Receptor, and Cardiovascular Disease in Obesity
(clinicaltrials.gov)
- P4 | N=79 | Completed | Sponsor: Brigham and Women's Hospital | Active, not recruiting ➔ Completed | Trial completion date: Feb 2026 ➔ Sep 2025 | Trial primary completion date: Jan 2026 ➔ Sep 2025
Trial completion • Trial completion date • Trial primary completion date • Cardiovascular • Genetic Disorders • Hypertension • Metabolic Disorders • Obesity
September 20, 2024
Aldosterone, the Mineralocorticoid Receptor, and Cardiovascular Disease in Obesity
(clinicaltrials.gov)
- P4 | N=80 | Active, not recruiting | Sponsor: Brigham and Women's Hospital | Recruiting ➔ Active, not recruiting
Enrollment closed • Cardiovascular • Genetic Disorders • Hypertension • Metabolic Disorders • Obesity
July 23, 2024
DECONGEST: Diuretic Treatment in Acute Heart Failure With Volume Overload Guided by Serial Spot Urine Sodium Assessment
(clinicaltrials.gov)
- P4 | N=107 | Completed | Sponsor: Vrije Universiteit Brussel | Recruiting ➔ Completed | Trial primary completion date: Mar 2024 ➔ Jul 2024
Trial completion • Trial primary completion date • Cardiovascular • Congestive Heart Failure • Heart Failure • CST3
September 21, 2023
DECONGEST: Diuretic Treatment in Acute Heart Failure With Volume Overload Guided by Serial Spot Urine Sodium Assessment
(clinicaltrials.gov)
- P4 | N=104 | Recruiting | Sponsor: Vrije Universiteit Brussel | Trial completion date: Jul 2023 ➔ Apr 2024 | Trial primary completion date: Jul 2023 ➔ Mar 2024
Trial completion date • Trial primary completion date • Cardiovascular • Congestive Heart Failure • Heart Failure
June 15, 2022
DECONGEST: Diuretic Treatment in Acute Heart Failure With Volume Overload Guided by Serial Spot Urine Sodium Assessment
(clinicaltrials.gov)
- P4 | N=104 | Recruiting | Sponsor: Vrije Universiteit Brussel | Not yet recruiting ➔ Recruiting
Enrollment open • Cardiovascular • Congestive Heart Failure • Heart Failure
June 09, 2022
DECONGEST: Diuretic Treatment in Acute Heart Failure With Volume Overload Guided by Serial Spot Urine Sodium Assessment
(clinicaltrials.gov)
- P4 | N=104 | Not yet recruiting | Sponsor: Vrije Universiteit Brussel
New P4 trial • Cardiovascular • Congestive Heart Failure • Heart Failure
January 27, 2021
Aldosterone, the Mineralocorticoid Receptor, and Cardiovascular Disease in Obesity
(clinicaltrials.gov)
- P4; N=80; Recruiting; Sponsor: Brigham and Women's Hospital; Not yet recruiting ➔ Recruiting
Enrollment open • Cardiovascular • Genetic Disorders • Hypertension • Metabolic Disorders • Obesity • MRI
August 19, 2020
Aldosterone, the Mineralocorticoid Receptor, and Cardiovascular Disease in Obesity
(clinicaltrials.gov)
- P4; N=80; Not yet recruiting; Sponsor: Brigham and Women's Hospital
New P4 trial • Cardiovascular • Genetic Disorders • Hypertension • Metabolic Disorders • Obesity
October 18, 2017
"@Novartis argentina . es una irresponsabilidad que no tengan HYGROTON en farmacias"
(@soy_financista)
Biosimilar
August 16, 2019
Die HCT-Alternative Hygroton® ist ab sofort wieder lieferbar.
(PubMed, MMW Fortschr Med)
- No abstract available.
Journal
1 to 10
Of
10
Go to page
1